# "Watch and Wait" After Neo-adjuvant Chemoradiotherapy for Primary Locally Advanced Rectal Cancer.

> **NCT03402477** · — · TERMINATED · sponsor: **Helse Stavanger HF** · enrollment: 86 (actual)

## Conditions studied

- Rectal Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03402477
- **Lead sponsor:** Helse Stavanger HF
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-01-10
- **Primary completion:** 2020-11-19
- **Final completion:** 2024-04-19
- **Target enrollment:** 86 (ACTUAL)
- **Why stopped:** Suspicion of adverse events
- **Last updated:** 2024-04-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03402477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03402477, ""Watch and Wait" After Neo-adjuvant Chemoradiotherapy for Primary Locally Advanced Rectal Cancer.". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03402477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*